Small Molecules Targeting Viral RNA.

Area of Science:

• Virology
• Medicinal Chemistry
• Molecular Biology

Background:

• Most current antivirals target viral proteins, leaving a gap in therapeutic options.
• Viral RNA genomes contain structured elements crucial for viral replication, presenting a novel target class.
• Targeting viral RNA offers a promising strategy to develop new antiviral therapies.

Purpose of the Study:

• To review methodologies for identifying and developing RNA-targeting antiviral compounds.
• To highlight existing small molecules that target specific viral RNA structures.
• To discuss the potential of RNA as a therapeutic target for viral infections.

Main Methods:

• Determination of RNA structures using biochemical and cellular methods.
• In silico screening of compound libraries against RNA targets.
• Phenotypic assays to evaluate viral inhibition by RNA-targeting compounds.
• Review of literature on known small molecules targeting viral RNA elements.

Main Results:

• Structured RNA elements in viral genomes are viable targets for antiviral drug discovery.
• Methods for RNA structure determination and compound screening are advancing.
• Several small molecules targeting SARS-CoV-2, HIV, and other viral RNA elements have been identified.

Conclusions:

• Targeting viral RNA represents a significant and emerging strategy in antiviral drug development.
• Further research into RNA-structure-based drug discovery holds great promise for combating viral diseases.
• The development of novel antivirals targeting viral RNA elements is crucial for addressing current and future viral threats.